|
Synonyms: AD-62643 | ALN-62643 | ALN-CC5
Compound class:
Nucleic acid
Comment: Cemdisiran is a small interfering RNA (siRNA) that is intended to reduce complement component 5 (C5) production. The molecule is N-acetylgalactosamine (GalNAc) modified to enhance hepatic delivery via binding to liver-expressed asialoglycoprotein receptors (ASGRs).
Cemdisiran is a 1:1 complex of RNA1 (Am-sp-Am-sp-(2′-deoxy-2′-fluoro)G-Cm-(2′-deoxy-2′-fluoro)A-Am-(2′-deoxy-2′-fluoro)G-Am-(2′-deoxy-2′-fluoro)U-(2′-deoxy-2′-fluoro)A-(2′-deoxy-2′-fluoro)U-Um-(2′-deoxy-2′-fluoro)U-Um-Um-(2′-deoxy-2′-fluoro)A-Um-(2′-deoxy-2′-fluoro)A-Am-Um-Am), 3′-[[(2S,4R)-1-[29-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-14,14-bis[[3-[[3-[[5-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-1-oxopentyl]amino]propyl]amino]-3-oxopropoxy]methyl]-1,12,19,25-tetraoxo-16-oxa-13,20,24-triazanonacos-1-yl]-4-hydroxy-2-pyrrolidinyl]methyl hydrogen phosphate] and RNA2 (Um-sp-(2′-deoxy-2′-fluoro)A-sp-(2′-deoxy-2′-fluoro)U-Um-(2′-deoxy-2′-fluoro)A-Um-Am-(2′-deoxy-2′-fluoro)A-Am-(2′-deoxy-2′-fluoro)A-Am-Um-Am-(2′-deoxy-2′-fluoro)U-Cm-(2′-deoxy-2′-fluoro)U-Um-(2′-deoxy-2′-fluoro)G-Cm-Um-Um-sp-Um-sp-Um-dT-dT) |
Classification ![]() |
|
| Compound class | Nucleic acid |
| Compound subclass | siRNA |
| Target | C5 mRNA |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 10269 | cemdisiran |
Synonyms ![]() |
| AD-62643 | ALN-62643 | ALN-CC5 |
Database Links ![]() |
|
| CAS Registry No. | 1639264-46-2 (source: WHO INN record) |
| Search PubMed clinical trials | cemdisiran |
| Search PubMed titles | cemdisiran |
| Search PubMed titles/abstracts | cemdisiran |